Status:

ACTIVE_NOT_RECRUITING

Efficacy of Non-Ablative Radiofrequency on Vaginal and Sexual Health in Postmenopausal Women

Lead Sponsor:

University of Castilla-La Mancha

Conditions:

Genitourinary Syndrome of Menopause

Vaginal Health

Eligibility:

FEMALE

40-65 years

Phase:

NA

Brief Summary

This study will test if non-ablative monopolar radiofrequency can help improve vaginal tissue and reduce symptoms of Genitourinary Syndrome of Menopause (GSM) in postmenopausal women. The study is a d...

Detailed Description

The purpose of this study is to evaluate the efficacy of non-ablative monopolar radiofrequency (RF) treatment in improving vaginal tissue regeneration and alleviating symptoms of Genitourinary Syndrom...

Eligibility Criteria

Inclusion

  • Age between 40 and 65 years.
  • Postmenopausal women (defined as no menstrual period for at least 12 months).
  • Experiencing symptoms of Genitourinary Syndrome of Menopause (GSM), such as vaginal dryness, irritation, or discomfort.
  • Experiencing discomfort or complaints during vaginal penetration. Engaging in sexual activity (at least once a month).
  • Willing to participate in the study and sign the informed consent form.

Exclusion

  • Presenting with active vaginal infections.
  • Presence of neurological, neoplastic, or sexually transmitted diseases.
  • Presenting with vulvodynia or vaginismus.
  • Prolapse grade 2 or higher.
  • Presenting with altered sensitivity in the pelvic area.
  • Being a pacemaker carrier or having any device that contains batteries.
  • Hormonal treatment with estrogens in the last 3 months.
  • History of radiotherapy in the pelvic area.
  • Recent pelvic surgery (within the last 6 months).
  • Being on anticoagulant treatment.
  • Having undergone laser treatment in the pelvic area or ablative vaginal rejuvenation in the last 6 months.
  • Cognitive impairment that prevents answering the questionnaires.

Key Trial Info

Start Date :

April 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 15 2025

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT06925139

Start Date

April 15 2024

End Date

June 15 2025

Last Update

April 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Castilla-La Mancha

Toledo, Spain, 45000